Abstract: Techniques are provided for generating plateau-shaped cardioversion shocks having reduced lead edge voltages. The reduced leading edge voltages are provided primarily to reduce the likelihood that any cardiac pain receptors will fire twice during a single cardioversion shock. Other techniques described herein relate to the generation of plateau-shaped shocks without reduced leading edge voltages. Still other techniques pertain to the generation of pre-pulse pain inhibition (PPI) pulses, particularly PPI pulses having chevron-shaped waveforms.

Abstract: A system and method are provided for discriminating supra-ventricular tachycardia (SVT) from ventricular tachycardia (VT). A monitoring EGM signal is acquired during a sensing window timed according to the time of R-wave detection on a reference EGM signal. A normal sinus rhythm (NSR) template is generated using the monitoring EGM signal during the time-referenced sensing window. During an unknown rhythm, the monitoring EGM signal sensed during the time-referenced sensing window is compared to the NSR template for use in computing a morphology metric. The morphology metric is compared to a VT/VF detection threshold for discriminating SVT from VT/VF.

Abstract: Methods for determining a surface geometry of an object, including determining a first projection matrix based on a first imaging device, determining a second projection matrix based on a second imaging device, obtaining at least one first two-dimensional (2D) image of the object using the first imaging device, obtaining at least one second 2D image of the object using the second imaging device, determining a contour of the object in the first 2D image and the second 2D image, and, based on the at least two contours, the first projection matrix, and the second projection matrix, reconstructing 3D data associated with the surface of the object. In one embodiment, the object can be a heart.

Abstract: Adjusting the pacing energy involves performing a plurality of capture threshold tests, each capture threshold test measuring a capture threshold of the heart. One or more measured captured thresholds are selected, including at least one capture threshold that is higher relative to other measured capture thresholds acquired by the plurality of capture threshold tests. The pacing energy is adjusted based on the one or more selected capture thresholds.

Abstract: Systems, devices and methods for identifying, displaying and assisting in correlating health-related data. One aspect is a programmable device having machine executable instructions for performing a method for use in correlating data to manage a patient's health. In various embodiments, data related to the patient's health is acquired. The acquired data includes one or more trended health-related parameters, and at least one of one or more predetermined health-related events and one or more health-related alerts. Correlations are identified. The one or more trended health-related parameters and the at least one of the one or more predetermined health-related events and the one or more health-related alerts establish a causal relationship between the acquired data and the patient's health.

Abstract: An implantable electrode assembly for gripping nerves or other bodily structures is disclosed. The assembly comprises first and second spines containing first and second leads with at least one electrode cross rail joining the spines and at least one electrode providing a route for electrical conduction between the first and second lead. Mating structures on the spines allow the spines to be joined for securely attaching the assembly around the nerve.

Abstract: An electrical contact for use in the header assembly of an implantable tissue stimulator includes a metal housing having a base and a sidewall where the opening in the base is adapted to receive the terminal of a medical lead therethrough. An electrical contact support member is welded to the edge of the sidewall and affixed to the support member are a plurality of spring members that are tangent to an imaginary circle whose diameter is slightly less than the outside diameter of the lead terminal contact rings. When the contacts are axially aligned in the device header, the terminal of an electrical lead may be longitudinally inserted into the header to establish electrical contact with device feedthrough wires that are joined to the electrical contacts in the header.

Abstract: A system, method, or device determines whether noise is present on a sampled and/or digitized sensed intrinsic cardiac signal based on a moving count of turning/inflection points of the signal. If noise is detected, the manner in which the cardiac signal is acquired, or the manner in which the device operates in response to the acquired cardiac signal (or both) is altered to reduce the risk of erroneously detecting noise as a heart depolarization and, therefore, inappropriately triggering or withholding therapy.

Abstract: An external programmer module adapted for physical and electrical connection to existing clinical monitoring and/or therapy instrumentation is provided for achieving bi-directional communication with an implantable medical device (IMD). The programmer module includes telemetry circuitry necessary for communicating with an IMD and a connector that allows electrical connection to a clinical instrument such as a patient monitor or external defibrillator. The connector is adapted to connect the programmer module with the power supply of the clinical instrument and may connect the programmer module with one or more features or subsystems of the clinical instrument, such as, a central processing system, a printer, an electronic storage medium, a user interface, a communications interface, or graphical display.

Abstract: Methods and devices for cutaneous testing of a patient for the purpose of implanting and/or placing electrodes for electrical cardiac stimulation. In an example, a cutaneous electrode system is placed and used to observe cardiac signal sensing and/or simulate cardiac stimulation. The method may include identifying locations for improved sensing or simulation, and implanting a device or system such that implanted electrodes are placed to correspond to cutaneously identified locations.

Abstract: A wrist-worn or arm band worn heart rate variability monitor is provided. Heart rate variability (“HRV”) refers to the variability of the time interval between heartbeats and is a reflection of an individual's current health status. Over time, an individual may use the results of HRV tests to monitor either improvement or deterioration of specific health issues. Thus, one use of the HRV test is as a medical motivator. When an individual has a poor HRV result, it is an indicator that they should consult their physician and make appropriate changes where applicable to improve their health. If an individual's HRV results deviate significantly from their normal HRV, they may be motivated to consult their physician. In addition, the inventive monitor is capable of monitoring the stages of sleep by changes in the heart rate variability and can record the sleep (or rest) sessions with the resulting data accessible by the user or other interested parties.

Abstract: A method for stimulating angiogenesis is provided that includes the use of an electrical output channel adapted to deliver a sub-threshold voltage, a lead that includes a proximal end adapted to be electrically connected to the electrical output channel and a distal end adapted to be placed in the blood conduit where the distal end of the lead is adapted to deliver a treatment agent that stimulates therapeutic angiogenesis, and at least one electrode on the distal end of the first lead.

Abstract: An exemplary method includes providing a filling pressure parameter, providing a perfusion parameter, determining a hemodynamic profile based at least in part on the filling pressure parameter and the perfusion parameter and adjusting a stimulation parameter of an implantable cardiac therapy device based at least in part on the hemodynamic profile. Other exemplary methods, devices, systems, etc., are also disclosed.

Abstract: In an embodiment, an article includes a primary surface, and a pattern of spaced dissimilar materials, on the primary surface. The pattern is to spontaneously produce electrical surface currents when brought into contact with an electrically conducting solution.

Abstract: Leads and introduction tools are proposed for deep brain stimulation and other applications. Some embodiments of the present invention provide lead designs with which may be placed with a stylet, while others do not require a stylet. Some lead embodiments use standard wire conductors, while others use cable conductors. Several embodiments incorporate microelectrodes and/or microelectrode assemblies. Certain embodiments of the present invention provide introduction tools, such as cannula and/or cannula systems, which ensure proper placement of, e.g., leads.

Abstract: A device for electrostimulation of body tissue through a stimulation electrode, in which a stimulation outcome is detected, at least after delivery of a stimulation pulse, on the basis of detecting a drop in a voltage over time or a rise in a short-circuit current over time at a capacitance including at least one Hemholtz capacitance produced on the surface of the stimulation electrode in conjunction with surrounding body fluid or the body tissue, and wherein the drop in voltage or the rise in short-circuit current is representative of a characteristic drop in a myocardium impedance of the body tissue.

Abstract: An implantable electrode array (30) that can adopt a first configuration selected to allow the array (30) to be inserted into a cochlea (12) of an implantee and at least a second configuration in which the array can apply tissue stimulation. The array (30) comprises an elongate carrier (31) having a proximal end (37), a distal end (34), and an inner surface (35) conformable with the inner wall of the implantee's cochlea (12). A plurality of electrodes (36) are supported within the carrier (31) at respective spaced locations thereon in a region between the proximal end (37) and the distal end (34) with at least one of the electrodes having a surface that is at least adjacent the inner surface (35) of the carrier (31). The carrier (31) is formed in the second configuration from a first layer (32) and at least a second layer (32) of resiliently flexible material. A method of forming an array (30) is also described.

Abstract: A stimulation system includes a stimulation source, an implantable stimulation lead, an implantable sensing device, and a controller. The stimulation source generates and transmits stimulation pulses to stimulation electrodes on the stimulation lead. The stimulation electrodes deliver the stimulation pulses to target nerve tissue in a nerve pathway to cause paresthesia in a portion of the person's body. Each stimulation pulse induces an action potential in a number of nerve fibers in the nerve pathway. The sensing device includes sensing electrodes positioned proximate the nerve pathway that detect compound action potentials of nerve fibers stimulated by the stimulation pulses. The controller modifies the stimulation pulses generated by the stimulation source and delivered to the target nerve tissue by the stimulation electrodes based on the detected compound action potentials to maintain a substantially constant level of paresthesia in the portion of the person's body.

Abstract: A method and apparatus for measuring impedance for pathology assessment in a living being using convergent bioelectric lead fields is disclosed, including injecting a current between first and second electrodes implanted in a body of a living being, where the first and second electrodes define a first electric lead field oriented between the first and second electrodes. A potential difference is measured between third and fourth electrodes implanted in the body, where the potential difference results from the current injected between the first and second electrodes. The third and fourth electrodes define a second electric lead field oriented between the third and fourth electrodes. The first and second electric lead fields converge near an assessment site within the body, but are substantially separated otherwise. An impedance value is calculated based on the potential difference and the current injection, and is used to assess a pathology near the assessment site.

Abstract: An interface for selective excitation of a biological neural network is provided. The interface includes a microelectromechanical (MEMS) device having a deformable membrane, and a tactile-sensitive neural cell disposed on the deformable membrane. The cell on the deformable membrane senses motion or deformation of the membrane and provides a signal, responsive to membrane motion or deformation, to the biological neural network. Preferably, the deformable membrane and cell have about equal areas, to provide selective excitation. An interface array including at least two such interfaces is also provided. A retinal prosthesis interface array having, in each element of the array, a photodiode within the MEMS device for electrostatically actuating the deformable membrane is also provided. For this alternative, the cells and deformable membranes are preferably transparent.